|
The crude hazard ratios of having above borderline and adverse glucose profiles for each antihypertensive drug group |
||||
| Bivariate Analysis Crude Odds Ratios for above borderline results (95% C.I.) (≥ 6.1 mmol/l) |
p value |
Bivariate Analysis Crude Odds Ratios for adverse results (95% C.I.) (≥ 7.0 mmol/l) |
p value |
|
|
|
||||
| (1). β-blockers |
0.881 (0.586, 1.323) |
0.540 |
0.993 (0.459, 2.150) |
0.986 |
| (2). Thiazide Diuretics |
0.860 (0.530, 1.397) |
0.543 |
0.828 (0.316, 2.168) |
0.700 |
| (3). CCB |
0.604 (0.390, 0.933) |
0.022 |
1.043 (0.494, 2.204) |
0.911 |
| (4). RAS |
0.720 (0.280, 1.850) |
0.493 |
1.944 (0.572, 6.607) |
0.278 |
|
(CCB: Calcium channel blockers; RAS: drugs acting on the rennin angiotensin system. Glucose levels for desirable: ≤ 6.0 mmol/l, above borderline: ≥ 6.1 mmol/l; adverse: ≥ 7.0 mmol/l. The desirable group was used as the reference) | ||||
Wong et al. BMC Clinical Pharmacology 2008 8:6 doi:10.1186/1472-6904-8-6 |
||||